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Autism is a heritable but genetically complex disorder characterized by deficits in language and in reciprocal social
interactions, combined with repetitive and stereotypic behaviors. As with many genetically complex disorders,
numerous genome scans reveal inconsistent results. A genome scan of 345 families from the Autism Genetic Resource
Exchange (AGRE) (AGRE_1), gave the strongest evidence of linkage at 17q11-17q21 in families with no affected
females. Here, we report a full-genome scan of an independent sample of 91 AGRE families with 109 affected
sibling pairs (AGRE_2) that also shows the strongest evidence of linkage to 17q11-17q21 in families with no
affected females. Taken together, these samples provide a replication of linkage to this chromosome region that is,
to our knowledge, the first such replication in autism. Fine mapping at 2-centimorgan (cM) intervals in the combined
sample of families with no affected females reveals a linkage peak at 66.85 cM, which places this locus at 17q21.
Autism (MIM 209850) is a lifelong neuropsychiatric
condition with onset in early childhood. First described
in 1943 (Kanner 1943), it is characterized by impairments
in language and nonverbal communication, deficits in
reciprocal social interactions, and the presence of re-
stricted and repetitive behaviors. Cases of autism may
occur in conjunction with chromosomal anomalies, such
as duplications on the long arm of chromosome 15q11-
13, Rett syndrome (MIM 300005), and fragile-X syn-
drome (MIM 309550). However, these recognized con-
ditions explain only a small fraction of the observed
prevalence of autism, currently estimated to be as high
as 3 in 1,000 (Yeargin-Allsopp et al. 2003). Suggestions
of a variety of environmental and genetic risk factors
for idiopathic autism have resulted in inconsistent find-
ings, and the specific etiologies remain unknown. An
autism concordance rate of 92% in MZ twin pairs versus
10% in DZ twin pairs (Bailey et al. 1995) implies that
there is a substantial genetic contribution to the risk.
However, these very divergent concordance rates indi-
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cate that autism is likely to result from the interactive
effects of multiple genes, making it genetically complex.
Given this level of complexity, it is not surprising that
the predisposing genes have thus far remained elusive.
To date, the results of eight independent full-genome
scans analyzed for the autism phenotype have been re-
ported (Barrett et al. 1999; Philippe et al. 1999; Risch
et al. 1999; Buxbaum et al. 2001; International Mo-
lecular Genetic Study of Autism Consortium [IMGSAC]
2001; Auranen et al. 2002; Shao et al. 2002; Yonan et
al. 2003). Multiple suggestive but not significant linked
loci have emerged from each of these individual studies.
A meta-analysis (Badner and Gershon 2002) of four of
these autism genome scans (Barrett et al. 1999; Philippe
et al. 1999; Risch et al. 1999; IMGSAC 2001) provided
evidence of linkage to chromosome 7. Recently, an an-
alysis that considered all eight independent genome scans
and focused on detecting common linked regions applied
criteria of a maximum LOD score (MLS) 11.5 and a
distance of no more than 10 cM between linkage peaks
(Smalley et al., in press). The region on chromosome 7
did not satisfy these criteria, and only one region, 17p11-
17q11, was linked to autism in more than one of these
studies (IMGSAC 2001; Yonan et al. 2003). The lack
of consistent linkage results for genetically complex dis-
orders such as autism is not surprising. This is likely due
to study differences in such factors as family ascertain-
ment, the instruments used to diagnose autism, the eth-
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2 82 164 82
3 9 27 27
Total 91 191 109
Malea:
2 44 88 44
3 4 12 12
Total 48 100 56
Mixedb:
2 38 76 38
3 5 15 15
Total 43 91 53
a Sibships with only affected males.
b Sibships with at least one affected female.
nicity of the sample, and the analytic methods employed.
Genetic heterogeneity coupled with stochastic fluctua-
tions among samples can also contribute to inconsistent
linkage results.
Thus, given the likely genetic complexity of autism
and the lack of replication, studies designed to confirm
linkage in independent, well-matched samples are criti-
cal prior to extensive fine-mapping and association stud-
ies. Rules for confirming linkage, developed in the 1970s
for Mendelian disorders, preclude the possibility of a
replication if there is an overlap in personnel between
two studies. These criteria may be too stringent for ge-
netically complex disorders, and Vieland (2001) presents
a strong argument for their reformulation. We suggest
that an independent sample, from the same cohort, in
which family ascertainment, methods of diagnosis, and
analytic approaches are identical may be the best sample
to use when testing for replication. However, autism co-
horts that are large enough to contain independent sam-
ples are rare.
The Autism Genetic Resource Exchange (AGRE) co-
hort currently consists of ∼500 nuclear families, each
with a sibling pair that meets narrow, “not quite autism”
(NQA), or broad definitions of autism (Geschwind et al.
2001). In these families, ascertained in the United States
through a proband with autism spectrum disorder and
a potentially affected sibling, the parents or caregivers
of each child were queried using the Autism Diagnostic
Interview-Revised (ADI-R) (Lord et al. 1994). The ADI-
R is constructed to diagnose autism on the basis of the
classifications of the International Statistical Classifica-
tion of Diseases and Related Health Problems, 10th Re-
vision (World Health Organization 1992), and the Di-
agnostic and Statistical Manual of Mental Disorders, 4th
Edition (American Psychiatric Association 2000). The
algorithms associated with the ADI-R are used by AGRE
to classify the children into the categories of narrow
autism, broad spectrum disorder, or NQA. The specific
criteria for classification as NQA are listed on the AGRE
Web site. Those who do not satisfy the criteria for nar-
row autism or NQA are classified as having broad spec-
trum disorder if they display patterns of impairment con-
sistent with those of pervasive developmental disorders
but do not meet the criteria for autism because of their
age at onset. Nonidiopathic cases of autism—which in-
clude those having a premature birth, evidence of a peri-
natal insult, another diagnosed psychiatric disorder, a
small nuclear ribonucleoprotein polypeptide N (SNRPN)
chromosome 15 duplication, fragile-X syndrome, or an
abnormal imaging or medical test—were omitted from
these analyses. MZ twin pairs were omitted from the
linkage analyses, although the DZ twin pairs were re-
tained. AGRE has human subjects’ approval from the
Western Institutional Review Board, and the current
study has the approval of the institutional review board
of the University of California at Los Angeles (UCLA).
In a previously reported full-genome–scan linkage an-
alysis of the first 345 families (AGRE_1) with at least
broad spectrum disorder that were genotyped for 335
multiallelic markers with a sex-averaged map, an MLS
of 2.04 ( ) was observed at 17q11 (Yonan et al.P ! .002
2003). Additional 17q11 markers genotyped at inter-
marker distances of ∼2 cM resulted in a multipoint MLS
of 2.83 ( ) at 52 cM. Since males predominateP ! .00029
among autistic children, Stone and colleagues (2004)
stratified this sample into 148 sibships with no affected
females to explore the possibility that there are male-
specific loci contributing to autism. This resulted in an
MLS of 4.3, revealing evidence of significant linkage to
17q11 (Stone et al. 2004). In a subsequent analysis of
a diagnostic subset of these data, the posterior-prob-
ability-of-linkage statistic, which allowed for different
male and female recombination fractions and parent-of-
origin effects, obtained a peak on chromosome 17 at 45
cM (Bartlett et al. 2005).
Here, we undertook a full-genome scan in an inde-
pendent sample of 109 sibling pairs with at least broad
spectrum disorder from the 91 families of AGRE_2 (ta-
ble 1). The parents and affected offspring were geno-
typed for 401 multiallelic markers by the Center for
Inherited Disease Research, by use of a marker panel
different from the one genotyped in AGRE_1. There
were 236 markers common to both scans. The markers
had an average spacing of 9 cM, and no intermarker
gap was 120 cM. A genotyping error rate of 0.02% was
inferred by examination of ∼11,000 repeat genotypes,
and a 3.22% rate of missing data was observed in these
pedigrees. Mendelian errors were identified using the
GAS software, and the marker data were replaced with
unknown genotypes for these families. Misspecifications
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Figure 1 MLS for a whole-genome scan, by chromosome, of
109 autistic sibling pairs in 91 families in AGRE_2. Those regions
showing an MLS 11.0 have been identified with the name of the marker
nearest the peak.
Figure 2 Chromosome 17 linkage-analysis MLSs of 109 autistic sibling pairs from AGRE_2 (gray line). MLSs obtained by stratifying
the sibships into those with no autistic females are indicated by a black line. MLSs from sibships with at least one autistic female are indicated
by a dashed line. The additional gray dashed peak represents the location and MLS plot from the analysis of AGRE_1 sibships with no affected
females. The peak marker is in boldface type.
of family relationships were tested using the RELCHECK
software (Boehnke and Cox 1997; Broman and Weber
1998), and a pair of MZ twins was identified and elimi-
nated, resulting in 109 sib pairs for the analysis. The
map order and sex-averaged intermarker distances were
estimated using the Marshfield marker map (see Center
for Medical Genetics Web site).
As in the original analysis of AGRE_1 (Yonan et al.
2003), multipoint MLSs were generated for AGRE_2,
by the Genehunter software (Kruglyak et al. 1996), at
1-cM intervals along the chromosomes. No regions of
significant linkage were observed for AGRE_2, and only
two loci exhibited LOD scores exceeding the replication
threshold of 1.4 ( ) posed by Lander and KruglyakP ! .01
(1995). The complete results of this scan can be found
in figure 1. A 12-cM region on 3p14-3p12 had a peak
at 105 cM near D3S2406, with an MLS of 1.8, but there
was no evidence of linkage to that chromosomal region
in AGRE_1. However, a 25-cM region with all LOD
scores 11.4 on 17q11-23 had a peak at 61 cM with an
MLS of 1.9 near D17S1299 (fig. 2). To assess whether
the linkage signal was derived from the 48 families with
no affected females (table 1), as seen in AGRE_1 (Stone
et al. 2004), we applied the same strategy to AGRE_2
on chromosome 17. Strikingly, multipoint analyses of
AGRE_2 stratified into the 56 sibling pairs from the sib-
ships containing no affected females revealed an MLS
of 4.1 with a linkage peak at 61 cM in 17q21. Figure
2 shows the MLS plots for AGRE_2 stratified into 56
pairs from the 48 sibships with no affected females, for
the 53 pairs from the 43 sibships with at least one af-
fected female, and for their combination of 109 pairs
from the 91 sibships. These linked regions show a con-
siderable overlap, and it is likely that the 9-cM sepa-
ration between the peak LOD scores is due to the dif-
ferences between the two samples in the distributions of
markers in this region.
We examined the linkage evidence in detail to evaluate
whether these study samples together provide a statis-
tical replication of linkage to a single locus on 17q11-
21, although we recognized that the replication would
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SHARED IBD (P) FOR
Total Sample Malea
44 .54 (.007) .57 (.003)
46 .55 (.005) .58 (.002)
48 D17S1871 .55 (.003) .58 (.001)
50 D17S1824 .56 (.002) .58 (.001)
51 D17S1294 .56 (.002) .58 (.001)
52 D17S1800 .56 (.002) .59 (.0009)
53 D17S798 .55 (.005) .59 (.0009)
54 .54 (.01) .58 (.001)
56 D17S1293 .53 (.04) .57 (.004)
58 .53 (.05) .56 (.008)
60 .53b .55 (.02)
62 D17S1299 .53b .55 (.04)
64 .53b .54 (.04)
NOTE.—Linkage at position 58 (shown in bold italics) is replicated
in AGRE_1 and AGRE_2 families with only affected males.
a Sibships with no affected females.
b Not significant.
Table 3




SHARED IBD (P) FOR
Total Sample Malea Mixedb
44 D17S2196 .56 (.04) .63 (.003) .47
48 .55 (.05) .62 (.004) .47
52 D17S1880 .55 (.04) .61 (.005) .49
56 .57 (.008) .64 (.0001) .49
58 .58 (.004) .65 (.00002) .49
60 .59 (.003) .67 (.00001) .48
61 D17S1299c .59 (.003) .68 (.000009) .48
64 .58 (.004) .67 (.00001) .47
66 D17S2180 .58 (.007) .67 (.00004) .47
68 .58 (.004) .66 (.00006) .48
72 .58 (.002) .63 (.0003) .51
76 .58 (.002) .61 (.003) .54
80 .59 (.003) .59 (.02) .57
81 D17S1290 .59 (.004) .58 (.03) .57
84 .57 (.007) .56d .57
NOTE.—Linkage at position 58 (shown in bold italics) is replicated
in AGRE_1 and AGRE_2 families with only affected males.
a Sibships with no affected females.
b Sibships with at least one affected female.
c Peak marker.
d Not significant.
not occur at the linkage peak in either sample. We ap-
plied a formal criterion of significant linkage of P !
in one sample and in a second sample.000022 P ! .01
(Lander and Kruglyak 1995). Multipoint identical-by-
descent (IBD) allele-sharing statistics and their P values
were generated across the linked regions in AGRE_1 and
AGRE_2 separately, through use of the GENIBD and
SIBPAL programs of the Statistical Analysis for Genetic
Epidemiology (SAGE) software. For the affected sibling
pairs from AGRE_1, table 2 reports IBD allele-sharing
estimates and their corresponding P values at 2-cM in-
tervals and the genotyped markers for the total sample
and for the sibships that have no affected females. For
AGRE_2, table 3 reports the same information at 4-cM
intervals and genotyped markers and includes the IBD
allele-sharing estimates for the sibships that have at least
one affected female. These statistics are reported for the
regions with linkage, beginning at 44 cM, where AGRE_1
showed significant allele sharing ( ). Table 2 re-P ! .01
ports these statistics up to 64 cM, for comparison with
the results at the peak marker in AGRE_2. Statistics in
table 3 extend to 84 cM, beyond which the P value is
1.01. At position 58 cM, the proportions of IBD allele
sharing of .65 with and .56 withPp .00002 Pp
in families with no affected females indicate that.008
AGRE_2 linkage is replicated by AGRE_1 at the ge-
nomewide level of significance (tables 2 and 3).
Although linkage was replicated statistically, the peaks
from the two samples did not coincide. To resolve this
difference, we undertook additional fine mapping of 13
multiallelic markers in the combined AGRE samples.
The original genome scans of the two samples used dif-
ferent marker sets with different and uneven distribu-
tions of intermarker distances. Those markers were ex-
cluded from these new analyses. The fine-mapping mark-
ers were selected using the criterion that any bias that
could be introduced by their distribution or informative-
ness be minimized. The markers are between positions
at 48 and 82 cM, have ∼2–3-cM intervals, and have an
expected multipoint information content of.70 or bet-
ter in the combined sample. Two additional markers, at
24 and 100 cM, serve as anchors.
With use of the Genehunter software (Kruglyak et al.
1996), multipoint and single-point MLS scores were gen-
erated at 1-cM intervals across the region from 24 to
100 cM by use of a sex-averaged map of the separate
and combined samples of the sibships containing no af-
fected females. Plots of the multipoint MLSs in the sepa-
rate and combined stratified samples are shown in figure
3. Whereas peaks seen in the original genome scans of
AGRE_1 and AGRE_2 are observed at D17S1294 at 51
cM and at D17S1299 at 61 cM, respectively, in the pres-
ent fine-mapping analysis, the most significant LOD score
of 4.1 is at marker D17S2180, at a distance of 66.85
cM from the p telomere. A 1-LOD drop includes the
peak from the second scan, with an MLS of 3.6 at
D17S1299. The proportion of multipoint allele-sharing
IBD in the combined sample estimated at D17S2180 is
.59 ( ), by use of the SIBPAL software of thePp .00002
SAGE package. The analogous single-point estimate is
.58 ( ).Pp .00002
Some factors contributing to this successful stratifica-
tion strategy have been discussed in detail by Stone et
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Figure 3 Chromosome 17q fine-mapping linkage-analysis MLSs of 220 autistic sibling pairs with no affected females from AGRE_1 and
AGRE_2 separately (black and gray dashed lines, respectively) and combined (solid black line). Markers and their distances from the p telomere
(in parentheses) appear on the horizontal axis.
al. (2004). They include the fact that male and female
brains have different structures and function differently
and that the incidences of autism and other neurodev-
elopmental disorders are different between males and
females. Here, we turn to the reported analyses of other
genetically complex diseases for additional insight. We
first note that there have been similar sex-stratification
analyses that resulted in positive sex-specific linkage and
association findings for other complex traits. In a linkage
and association analysis of the insertion-deletion poly-
morphism of the angiotensinogen-converting enzyme
(ACE) gene, male-specific association and linkage find-
ings were seen for blood pressure traits in humans
(O’Donnell et al. 1998). In a complementary study, gene-
targeting experiments in mice provided additional evi-
dence that functional inactivation of the ACE gene con-
tributes to blood-pressure levels in males but not in
females (Krege et al. 1995). Loughlin and colleagues
(2000) were able to remove heterogeneity from a linkage
analysis of osteoarthritis and chromosome 2q by use of
sex stratification, and the positive linkage signal was
observed when the affected individuals were limited to
males. In a study of the linkage of inflammatory bowel
disease to the HLA region, sex stratification removed
heterogeneity and improved the LOD score from 1.2 to
4.5 in the male-only sibships (Fisher et al. 2002). In each
case, the mechanism by which the sex effect operates
needs additional investigation.
For possible positional candidate genes, the serotonin
transporter gene (SLC6A4), which codes for a protein
controlling the reuptake of serotonin in the synapse (Mur-
phy et al. 2004), is at 49 cM, under the original peak
in AGRE_1. It has been investigated by association stud-
ies of the combined AGRE_1 and AGRE_2 samples. No
evidence for allelic association was observed between the
putative functional promoter variant (5-HTTLPR) and
autism spectrum disorder; however, evidence of asso-
ciation was observed with two SNPs (A. Yonan and C.
Gilliam, personal communication). Given the peak in
the combined AGRE_1 and AGRE_2 samples, it is of
interest that a recent report addressed the sex-specific
genetic architecture of whole-blood serotonin levels in
806 Hutterites from a single pedigree (Weiss et al. 2005).
This trait is sexually dimorphic, and a QTL for male
serotonin levels was identified on 17q, with the linkage
peak at 66 cM, very close to the one identified in the
present study. An association with a SNP in the integrin
b3 (ITGB3) gene under the peak at 66 cM was reported
by the same group (Weiss et al. 2004). ITGB3 is a bio-
logically plausible candidate for autism susceptibility be-
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cause it is a cell-adhesion molecule involved in nervous
system development, including the processes of cell pro-
liferation, migration, differentiation, and synapse mat-
uration (Sajid et al. 2002). This gene provides a good
positional candidate for follow-up studies of the com-
bined sex-stratified AGRE sample, since its disruption
would clearly affect brain development and functioning,
although potentially in a subtle manner.
In conclusion, linkage analyses of 109 autistic sibling
pairs from 91 AGRE families in combination with analy-
ses of those pairs from an independent sample of 345
families from the same cohort establish three points.
First, stratification of families with autism into only
those with affected males reveals significant linkage to
17q11-21 in both samples, supporting the value of this
approach. Second, linkage to 17q11-21 is replicated at
the genomewide level of significance; this provides the
first formal replication of a locus for idiopathic autism.
Third, the multipoint linkage evidence in the combined
sample localizes the peak to 17q21.
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